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Abstract 26 
This study evaluates the influence of novel galacto-oligosaccharides derived from 27 
lactulose (GOS-Lu), kojibiose or 4’-galactosyl-kojibiose in hematological parameters of 28 
Fe homeostasis using Fe-deficient animals. Liver TfR-2, IL-6, NFκB and PPAR-γ 29 
expression (mRNA) were also determined by RT-qPCR analyses, and active hepcidin 30 
peptide production and short chain fatty acids by LC coupled to MS/MS or UV 31 
detection. Feeding animals with GOS-Lu or kojibiose together with FeCl3 increased 32 
hemoglobin (Hb) production (by 17%) and mean Hb concentration into erythrocytes 33 
relative to animals administered with FeCl3 alone (14.1% and 19.7%, respectively). 34 
Animals administered with prebiotics showed decreased plasmatic hepcidin levels, 35 
contributing to a higher intestinal absorption of the micronutrient. These data indicate 36 
that concurrent administration of these potentially prebiotic oligosaccharides together 37 
with a supplement of Fe ameliorates inflammation-mediated perturbations in the liver, 38 
according to the particular structure of the prebiotic compound, and result an attractive 39 
strategy to improve Fe absorption. 40 
 41 
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1. INTRODUCTION 50 
Iron (Fe) deficiency is the most prevalent nutrient deficiency worldwide, affecting 51 
nearly 2 billion people, particularly populations at risk such as women and children.
1
 52 
This nutritional deficiency is associated, among others, to aggravated severity of 53 
diseases based in defective function of immune responses.
 2
 In this sense, it is widely 54 
accepted the dynamic mutualism between the host and the commensal microbiota which 55 
has deep implications for health, and contributes to the maintenance of intestinal 56 
immune homeostasis. The intestinal tract harbors a massive and diverse microbiota, 57 
including both anaerobes and aerobes, containing at least 100 times as many genes as 58 
within our own genome with an enormous impact in the digestion of dietary 59 
compounds, salvage of energy, supply of (micro)nutrients and transformation of 60 
xenobiotics.
 3
 The composition of this bacterial ecosystem is dynamic and potentially 61 
modifiable in response to dietary factors. 62 
Prebiotics are selectively fermentable ingredients that induce specific changes in the 63 
composition and/or activity of the gastrointestinal microbiota, thus conferring potential 64 
benefit(s) on host health.
 4
 This concept assumes that they exert major effects in the 65 
colon, where most of gastrointestinal microorganisms live. However, accumulating 66 
evidences demonstrated that prebiotics also influence mineral absorption, which takes 67 
place mainly in the upper part of the intestine. The most compelling data have 68 
demonstrated the prebiotic-promoted positive effects increasing calcium and 69 
magnesium absorption and also that zinc balance can be improved by their 70 
consumption.
5
 However, data from in vivo studies have showed conflicting data about 71 
iron absorption. 
6,7
 72 
Fermentation of prebiotics leads to the production of short chain fatty acids (SCFA) 73 
able to modulate cytokines secretion 
7
 and stimulate mucin production.
 9
 Prebiotics such 74 
as sialyl-lactose and Raftilose P95 (oligofructose) promoted anti-inflammatory effects 75 
via activation of peroxisome proliferator activator receptor (PPAR)-γ.
 10
 Other 76 
inflammatory mediators such interleukin (IL)-6 and the hepatic hepcidin have important 77 
roles in iron homeostasis.
 11
 Anemia of chronic diseases usually occurs as secondary to 78 
infections and it is characterized by an immune activation with an increase in 79 
inflammatory cytokines and hepcidin levels.
 12
 80 
In humans, recent research about the influence of prebiotics on iron absorption 81 
studied the influence in absorption processes and nutritional status concerning the 82 
micronutrient.
 7
 These studies mainly investigated the effects of fructooligosaccharides 83 
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(FOS) such as inulin showing positive trend in the fractional iron absorption in women 84 
with low iron status, although this influence did not result statistically significant. The 85 
effects of inulin on iron absorption appear of much higher magnitude in pig 
6
 and rat 86 
models.
 13
 Similarly to inulin, feeding galactooligosaccharides (GOS) with a degree of 87 
polymerization of 2-6 to young healthy men did not improve nutritional biomarkers of 88 
iron status.
 14
 A common conclusion of these studies is that inulin does not interfere 89 
with the molecular mechanisms of iron absorption. To the best of our knowledge there 90 
are no experimental data with in vivo animal models about the influence of either GOS 91 
derived from lactulose (GOS-Lu) and kojibiose (2-O-α-D-glucopyranosyl-α-D-92 
glucopyranose) as well as 4’-galactosyl-kojibiose on iron absorption. 93 
Likewise, scarce data are available associating micronutrient intake with markers of 94 
inflammation.
 11,15
 Data from human studies provided evidences about the positive 95 
effects of inulin in inflammatory processes 
16
 preventing impaired iron homeostasis. 96 
This is concordant with the results from a long-term feeding study indicating the 97 
negligible impact of consumption of prebiotic and Bifidobacterium lactis HN019 98 
fortified milk on nutritional Fe indicators, although, the proportion of children with Fe 99 
deficiency was reduced by 39%. 
17 
These positive benefits could also be favored by 100 
bifidobacteria-mediated influence in liver Fe homeostasis.
 18
 101 
In the present study an in vivo iron-deficient rat model was used to evaluate the 102 
influence of a mixture of novel GOS-Lu, kojibiose or 4’galactosyl-kojibiose on 103 
restoration of hemoglobin (Hb) levels and liver expression of inflammatory biomarkers 104 
and hepcidin production. SCFA profile in the colon contents of the different 105 
experimental groups was measured to monitor the effect of prebiotic compounds on gut 106 
microbiota metabolic activity. 107 
 108 
2 MATERIALS AND METHODS 109 
2.1 Enzymatic synthesis of the studied potentially prebiotic oligosaccharides  110 
Enzymatic synthesis of GOS derived from lactulose (GOS-Lu) was carried out via 111 
the hydrolysis and transgalactosylation of the prebiotic carbohydrate lactulose 112 
(Duphalac, Solvay Pharmaceuticals) by using a β-galactosidase from Aspergillus oryzae 113 
and following the procedure described elsewhere 
19
 with slight modifications. 114 
Oligosaccharide mixture with high proportion (i.e., 44%) of 4’-galactosyl-kojibiose 115 
(O-β-D-galactopyranosyl-(1→4)-O-(α-D-glucopyranosyl-(1→2))-α-D-glucopyranose) 116 
was obtained through a biotechnological process based on the dextransucrase-catalysed 117 
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synthesis followed by a purification step with β-galactosidase hydrolysis and yeast 118 
treatment. Enzymatic synthesis was conducted with a dextransucrase from L. 119 
mesenteroides B-512F by the transfer of a glucosyl unit from the hydrolysis of sucrose 120 
to lactose acceptor through the formation of an α-(1→2)-glucosyl bond.
 20
 The 121 
oligosaccharide mixture obtained (38.5% lactose, 31.2% 4’-galactosyl-kojibiose, 21.3% 122 
fructose, 5.2% leucrose, 2.8% lactosucrose, 0.9% glucose and 0.1% sucrose) was 123 
purified by Kluyveromyces lactis β-galactosidase hydrolysis and Saccharomyces 124 
cerevisiae yeast treatment in order to reduce the large amount of lactose as well as 125 
eliminating residual monosaccharides and sucrose.  126 
Oligosaccharide mixture with high proportion of kojibiose (66%) was obtained from 127 
the complete hydrolytic action of a Kluyveromyces lactis β-galactosidase on 4’-128 
galactosyl-kojibiose, after removal of residual monosaccharides by using a 129 
Saccharomyces cerevisiae yeast treatment as previously shown.
 21
 130 
 131 
2.2 Animals 132 
Forty-two female Wistar albino rats, aged 3 weeks with an average weight of 61.4 ± 133 
5.6 g were obtained from the University of Valencia Animal Service. Animal 134 
experiments were carried out in strict accordance with the recommendations include in 135 
the Guide for the Care and Use of Laboratory Animals of University of Valencia 136 
(SCSIE, University of Valencia, Spain) and the protocol was approved by its Ethic 137 
Committee (A1351244049254). 138 
 139 
2.3 Experimental design 140 
Animals were randomly distributed into six different groups (n=7 per group), 1) a 141 
control group receiving a standard AIN-93G diet, and five iron-deficient groups 142 
receiving a AIN-76A diet (Harlan) for 15 days that were subjected to different 143 
treatments: 2) administered without FeCl3; 3) administered with FeCl3 (2.5 µg); 4) 144 
administered with FeCl3 together with GOS-Lu; 5) administered with FeCl3 together 145 
with kojibiose; and 6) administered with FeCl3 together with 4’-galactosyl-kojibiose. 146 
Potentially prebiotic oligosaccharides were administered at 0.5% (w/w daily 147 
consumption of diet) during two consecutive days. The rats were maintained in an 148 
environment of controlled temperature (21–23ºC), humidity (55 %) and light (12 h) – 149 
dark (12 h) cycle, with ad libitum food and mineral-free water available. Records of 150 
weight and food intake were collected daily. 151 
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After treatment, rats were anaesthetised (isofluran) and sacrificed by 152 
exsanguination. Whole blood samples were preserved in EDTA-treated tubes to prevent 153 
coagulation (at room temperature) for haematological analyses and the rest of the blood 154 
was used for hepcidin peptide quantification. Sections (±100 mg) of the liver were 155 
immersed in RNA later buffer (Qiagen, CA, USA) and snap-frozen in liquid nitrogen 156 
for gene expression analyses. Colon content samples were kept in 0.5 mL H2SO4 (2N) 157 
and immediately analysed for SCFA content. 158 
 159 
2.4 Hemoglobin (Hb) measurement 160 
Hb concentrations were measured photometrically using cyanmethemoglobin 161 
standard solution according to the manufacturer’s instructions (Sigma-Aldrich). This 162 
method is based on the oxidation of Hb and its derivatives (except sulfhemoglobin) to 163 
methemoglobin in the presence of potassium ferricyanide to form cyanmethemoglobin. 164 
The absorbance, measured at 540 nm, is proportional to the total Hb concentration.  165 
 166 
2.5 Hematological parameters 167 
The number of erythrocytes was calculated by using a Neubauer improved cell 168 
counting chamber and hematocrit was estimated by centrifugation of whole blood in 169 
microcapillar tubes. Mean corpuscular volume (MCV) was calculated using the 170 
following equation: (hematocrit x 10)/nº erythrocytes (10
6
/mm
3
 blood), and mean 171 
corpuscular Hb (MCH) (%) as: (hemoglobin (g/dL)x100)/hematocrit. The globular 172 
sedimentation speed (VSG) was determined according to the Westergren’s method as 173 
proposed by the International Council for Standardization in Hematology (ICSH). 174 
 175 
2.6 Real-time reverse transcription-polymerase chain reaction (RT-qPCR)  176 
Total RNA was extracted from liver tissue samples using an RNeasy mini kit 177 
(Qiagen) following the protocol provided by the manufacturer. One microgram of total 178 
RNA was converted to double-stranded cDNA using AMV Reverse Transcriptase 179 
(Promega, WI, USA). PCR was performed with primers designed for the following 180 
Rattus norvegicus genes: Hamp (forward: 5’- AGC GGT GCC TAT CTC CGG CA-3’; 181 
reverse: 5’- CGG AGG GGA GGC AGT GTG TTG-3’); TfR2 (forward: 5’- GGC AGA 182 
GTG GTC GCT GGG TG -3’; reverse: 5’- GGC CAG AGC TCG GCA GTG TG -3’); 183 
IL-6 (forward: 5´-TCT CGA GCC CAC CAG GAA C -3´; reverse: 5´-AGG GAA GGC 184 
AGT GGC TGT CA -3´); NFκB (forward 5’- CTT CTC GGA GTC CCT CAC TG-3’, 185 
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reverse 5’- CCA ATA GCA GCT GGA AAA GC-3’) ; PPARγ (forward 5’- TGA TCC 186 
TAC GGC CAG ACA GA-3’, reverse 5’-GGG AGG TTG TCC CTG GAA TG-3’) and 187 
β-actin (forward 5’- CTC TTC CAG CCT TCC TTC CT-3’; reverse 5’- TAG AGC 188 
CAC CAA TCC ACA CA-3’), the latter used as a housekeeping gene. The PCR mix 189 
(20 µL reaction volume) consisted of 7.5 µL SYBR Green I master mix, 1.3 µmol/L 190 
primers, and 2.5 µL cDNA. PCR reactions were performed in triplicate in a LightCycler 191 
480 (Roche) with the following program: 1 cycle at 95 ºC for 5 min, 35 cycles at 60 ºC 192 
for 20 s and 72 ºC for 45 s. Samples of each animal tissue were measured in duplicate 193 
and gene expression was expressed as fold-change. The relative mRNA expression of 194 
the tested gene compared to β-actin expression was calculated using the 2
-∆∆Ct
 method. 195 
 196 
2.7 Quantification of hepcidin 197 
All sample preparation steps were performed at room temperature as previously 198 
described.
 18
 Briefly, aliquots (50 µL) of plasma were mixed with 100 µL aliquot of 199 
acetonitrile (Burdick and Jackson, Muskegon, MI, USA) by pipetting. The samples 200 
were then centrifuged at 3,000 x g for 10 minutes at 4°C (Jouan, Winchester, VA, USA) 201 
and the supernatant (100 µL) was mixed with 0.02% (v/v) aqueous acetic acid. The 202 
analysis was performed on an Agilent HPLC system connected on line to quadrupole 203 
ion trap mass spectrometer (Bruker Daltonics, Billerica, MA) via an electrospray 204 
interface. The HPLC system was equipped with a quaternary pump, an in-line degasser, 205 
an automatic injector, and a variable wavelength absorbance detector set at 214 nm 206 
(1200 Series, Agilent Technologies, Waldbronn, Germany). The column used in these 207 
analyses was a BioBasic C18 (250 × 4.6 mm, 5 µm particle size) (Thermo, Waltham, 208 
MA, USA). The mobile phases consisted of, trifluoroacetic acid/isopropanol/water 209 
(0.125/1/500, v/v/v, A) and trifluoroacetic acid/isopropanol/water/methanol/acetonitrile 210 
(0.125/1/50/350/100, v/v/v/v/v, B). Aliquots (50 µL) of the precipitation supernatants 211 
were injected in each cycle and the analysis was performed using the following 212 
gradient: 0 min, 5 % B; 30 min, 90 % B; 33 min, 100 % B; 35 min, 100 % B; 45 min, 5 213 
% B. Two independent samples from each animal were analyzed. 214 
 215 
2.8 Analysis of short chain fatty acids (SCFA) 216 
Aliquots (0.17 ± 0.04 g) of colon samples were kept in 0.2 mL of 2N H2SO4. The 217 
samples were homogenized (1 min) using a TissueRuptor (Qiagen) and vortexed for 30 218 
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s. Afterwards, the mixtures were centrifuged (10,000 x g, 10 min) and the supernatant 219 
was collected and diluted (1:20) in deionized water prior filtration (0.45 µm, MillexGN, 220 
Millipore). 221 
The quantification of organic acids was carried out on 1200 Agilent HPLC system 222 
equipped with a multisolvent pump and a wavelength absorbance detector set at 214 nm 223 
(1200 Series, Agilent Technologies, Waldbronn, Germany). The separation was 224 
performed on a BioBasis C18 column (250 x 4.6 mm, 5 µm particle size) (Thermo, 225 
Waltham, MA, USA). The elution was performed using 1% acetronitrile in 20 mM 226 
phosphate buffer adjusted to pH 2.20 with phosphoric acid (A), water/acetronitrile 227 
(80/20, v/v, B) according to the following gradient: 0 min, 0 % B; 5 min, 0 % B; 12 min, 228 
10 % B; 19 min, 10 % B. The following organic acids were analyzed: formic acid, 229 
acetic acid, propionic acid, D-/L-Lactic acid, i-butyric acid, i-valeric acid. 230 
 231 
2.9 Statistical analysis 232 
Statistical analyses were performed using SPSS v.15 software (SPSS Inc., Chicago, 233 
IL, USA). Variance analysis by one-way method was used to compare the influence of 234 
feeding different prebiotic compounds in the iron-deficient groups of animals. 235 
Individual means were tested using pair-wise comparison with Tukey’s multiple 236 
comparison test when effects were significant. Statistical significance was established at 237 
P<0.05 for all comparisons. 238 
 239 
3. RESULTS 240 
3.1 Effects in hematological parameters and hepatic expression of transferrin 241 
receptor (TfR2) 242 
Animals fed with the Fe-deficient diet alone showed a significant decrease in 243 
hemoglobin (Hb) concentrations compared to animals fed with the standard diet (Table 244 
1). In this period of treatment (15 days) there were not provoked changes in the 245 
hematocrit, which have been reported to occur after 20 days in animals under a Fe-246 
deficient diet.
 22
 Nevertheless, the decrease in mean corpuscular hemoglobin 247 
concentration (MCH) became significantly (P<0.05) reduced in animals receiving the 248 
Fe-deficient diet. Animals administered with the supplement of Fe alone showed 249 
normalized Hb concentrations, but lower (P<0.001) than values quantified in controls. 250 
Notably, there were not quantified significant (P>0.05) alterations between the Hb 251 
concentration of animals administered with the supplement of Fe together with the 252 
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prebiotic compounds GOS-Lu or kojibiose. This prebiotic-promoted positive effect in 253 
Hb concentration was not observed in animals administered with 4’-galactosyl-254 
kojibiose. A similar trend with higher increases in MCH was calculated in animals 255 
administered with GOS-Lu and kojibiose in comparison to 4’-galactosyl-kojibiose or 256 
the supplement of Fe alone. There were not significant (P>0.05) changes in body weight 257 
gain in animals fed with the Fe-deficient diet compared to the controls at the end of 258 
period of study (data not shown). 259 
Changes in TfR2 expression (mRNA) levels in animals administered with the 260 
supplement of Fe alone or together with the oligosaccharides assayed are shown in 261 
Figure 1. Animals administered with the supplement of Fe alone showed a trend 262 
increasing (P>0.05) TfR2 expression levels in comparison to controls with normal Hb 263 
concentration. Feeding the supplement of Fe together with GOS-Lu or kojibiose did not 264 
affect TfR2 expression values. Notably, feeding animals with 4’-galactosyl-kojibiose 265 
down-regulated (P=0.001) TfR2 expression levels compared to controls, but to similar 266 
(P=0.28) levels found in animals fed with the Fe-deficient diet. 267 
 268 
3.2 Effects in hepcidin production and liver biomarkers 269 
The consumption of Fe-deficient diet did not provoke alterations in bioactive 270 
hepcidin peptide production relative to animals fed with the Fe-adequate diet (Figure 271 
2). Animals administered with the supplement of Fe alone exhibited a significantly 272 
(P=0.029) increased circulating hepcidin concentration. These animals showed hepcidin 273 
concentrations up to 1.64-fold that of control animals demonstrating the physiological 274 
inflammatory response at liver level. However, the concurrent administration of the 275 
supplement of Fe and all prebiotic compounds studied tended to decrease to similar 276 
values the circulating concentration of hepcidin that not differed from the control group. 277 
Changes in hepatic NFκB, IL-6 and PPARγ expression levels in the different 278 
treatment groups are shown in Figure 1. Nutritional deficiency of iron induced NFκB 279 
(Nuclear Factor Kappa-B) expression (mRNA), which was not normalized neither by 280 
the administration of the Fe supplement alone or together with none of the prebiotic 281 
compounds. Additionally, Fe-deficient animals showed increased IL-6 expression 282 
(mRNA) compared to control animals as well as those groups administered with the 283 
supplement of Fe alone and together with kojibiose. However, there were not significant 284 
differences in IL-6 mRNA levels in animals administered with GOS-Lu or 4’-285 
galactosyl-kojibiose relative to controls. All animals from the different treatment groups 286 
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showed an increased PPARγ expression (mRNA) compared to controls. The 287 
administration of the supplement of Fe alone decreased PPARγ expression values 288 
relative to Fe-deficient animals. Besides, animals administered with the Fe supplement 289 
together with the different prebiotic structures revealed significant differences affecting 290 
PPARγ expression in the different treatment groups. 291 
 292 
3.3 Effects in short chain fatty acids (SCFA) production 293 
The concentration of several different SCFA quantified in colon contents of animals 294 
from the different groups of treatment are shown in Table 2. Significant differences in 295 
the concentration of formic acid and i-valeric acid in colon content of Fe-deficient 296 
animals were found as compared to controls. On the other hand, the level of acetic, 297 
propionic, i-butyric and i-valeric acid was higher in animals administered with the 298 
supplement of Fe alone than those fed with the standard diet. Neither the concentration 299 
of propionic acid nor butyric acid in both Fe-adequate or deficient groups presented 300 
significant (>0.05) correlation with Hb levels. Animals fed the concurrent 301 
administration of the supplement of Fe together with GOS-Lu showed decreased 302 
concentration of i-valeric acid relative to animals administered with the supplement of 303 
Fe alone. Feeding animals with the supplement of Fe and kojibiose changed, but not 304 
significantly (P=0.065), the mean value for formic acid and normalized the levels of i-305 
valeric acid to values similar to concentrations found in controls. Animals administered 306 
with 4’-galactosyl-kojibiose exhibited lower concentration of formic, acetic, propionic, 307 
i-butyric and i-valeric acids in comparison to animals fed with the supplement of Fe 308 
alone. 309 
 310 
4. DISCUSSION 311 
This study demonstrated the rapid restoration of normal Hb levels in Fe-deficient 312 
animals fed with potential prebiotics such as GOS-Lu and kojibiose together with a 313 
supplement of FeCl3, to even higher (by 14%) mean values than those quantified in 314 
animals fed only with the supplement of Fe. This positive effect in Fe absorption is 315 
clearly evident in the increased MCH calculated in animals fed kojibiose. In contrast, 316 
4’-galactosyl-kojibiose showed a much less influence on the studied hematological 317 
parameters. These results highlight the role played by the oligosaccharide structure in 318 
mineral absorption. 319 
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The assayed oligosaccharides have been comprehensively characterized prior to this 320 
study. GOS-Lu is a complex mixture predominantly dominated by the presence of di- 321 
and trisaccharides (31% and 42%, respectively) followed by tetrasaccharides (24.6%) 322 
and pentasaccharides in trace amounts.
 23
 The disaccharide fraction was mainly 323 
composed of galactosyl-fructoses with 1→1, 1→4 (i.e., lactulose), 1→5, and 1→6 324 
glycosidic linkages, in addition to galactobioses linked by 1→1, 1→2, 1→3, 1→4, and 325 
1→6 glycosidic linkages, whereas the trisaccharide fraction was mainly composed by 326 
the trisaccharide 6′-galactosyl-lactulose.
 24
 327 
In the case of the mixture obtained with high proportion of kojibiose (2-O-α-D-328 
glucopyranosyl-α-D-glucopyranose), carbohydrate composition determined by GC-FID 329 
was as follows: 66% kojibiose, 20% leucrose, 8% yeast metabolites and 6% 330 
trisaccharides. Kojibiose was purified by LC-RID and identified by GC-MS.
 21
  331 
Carbohydrate composition of the mixture with high proportion of 4’-galactosyl-332 
kojibiose was determined by gas chromatography with flame ionization detector 333 
showing that it was composed of 44% 4’-galactosyl-kojibiose, 30% galactosylated 334 
derivatives, 13% kojibiose, 8% leucrose, 3% lactose and 2% yeast metabolites (minor 335 
amounts of polyalcohols and organic acids). 4’-galactosyl-kojibiose was isolated and 336 
chromatographically purified by LC-RID from the reaction mixture obtained and then 337 
fully characterized by 1D and 2D (
1
H, 
1
H) and (
1
H-
13
C) nuclear magnetic resonance 338 
studies (gCOSY, TOCSY, ROESY, multiplicity-edited gHSQC, and gHMBC).
 20
 339 
These results evidence the avidity of Fe-deficient organisms for the micronutrient 340 
and taken together with previous studies with humans 
7,14
 indicate that prebiotic-341 
mediated positive effects on Fe homeostasis are mostly relevant when suffering 342 
nutritional deficiency of the micronutrient. These human studies also stressed that the 343 
magnitude of the prebiotic-mediated effects seemed to be conditioned by the nutritional 344 
status on the micronutrient of the subjects. For example, feeding GOS to young healthy 345 
men did not improved nutritional biomarkers of Fe status.
 14
 Further studies in women 346 
with low iron status also pointed out the inulin-promoted improved (P<0.05) fractional 347 
iron absorption.
 7
 348 
Previous research associated the dietary micronutrient intake with markers of 349 
inflammation, which effects that can be aggravated after long-term consumption.
 15
 350 
Although, Fe absorption is tightly regulated and controlled at intestinal level these 351 
processes are influenced by the hepatic production of inflammatory mediators such as 352 
hepcidin 
18, 25
 and IL-6.
 18
 Serum hepcidin displays an inverse relationship with Fe 353 
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intestinal absorption either from foods or dietary supplements.
 11, 18
 Thus, prebiotic-354 
mediated decrease in the production of hepcidin (Fig. 2) is reflected in improved 355 
hematological parameters such as Hb and MCH (Table 1). These anti-inflammatory 356 
effects appear to be dependent on the prebiotic structure considered and can explain, at 357 
least in part, their differential capacity to influence Fe absorption. Human and 358 
experimental animal models indicate that control of liver inflammatory processes in 359 
response to free Fe can result in an improved iron homeostasis and nutritional status. 360 
The effects and influence in liver physiology of the prebiotic compounds assayed 361 
could be explained by differences in the monomer and linkage type of the different 362 
prebiotic compounds tested that also could influence their prebiotic selectivity. Data 363 
from animal studies have demonstrated the prebiotic effect of GOS-Lu (1% w/w diet for 364 
14 days) increasing the numbers of beneficial bifidobacteria and lactobacilli together 365 
with the number of Eubacterium rectale/Clostridium coccoides group and bacteroidetes.
 
366 
26
 However, from in vitro studies it has been calculated a high prebiotic index for 367 
kojibiose promoting increases in the numbers of bifidobacteria, but not for lactobacilli, 368 
Eubacterium rectale/Clostridium coccoides and bacteroidetes group.
 27
 In this context, it 369 
has been reported the inhibition of NFκB signaling by anaerobic commensal bacteria, 370 
particularly Bacteroides thetaiotaomicron exerted potential anti-inflammatory effects by 371 
promoting nuclear export of NFκB subunit relA in complex with PPAR-γ.
28
 However, 372 
the GOS-Lu mediated increase in Bacteroides spp. it is not reflected in a significant 373 
down-regulation of NFκB expression (mRNA) in this group of treatment (Fig. 1). 374 
PPAR-γ expression is also associated to insulin signaling and inhibition of monocyte 375 
and macrophage inflammatory responses by preventing the activation of nuclear 376 
transcription factors, such as NFκB, activating Protein-1 and STAT1 (Signal Transducer 377 
and Activator of Transcription-1.
 29
 Inulin is a heterogeneous collection of fructose 378 
polymers (glucosyl and fructosyl moieties), which are linked by β(2→1) bonds and a 379 
degree of polymerization ranged from 2 to 60. Besides, the prebiotic structures used in 380 
the present study are galactooligosaccharides, which are linked by α(1→2)-glucosyl 381 
bonds and predominantly dominated by the presence of di- and trisaccharides. These 382 
structural differences could explain the different expression patterns in relation to PPAR 383 
and NFB (Fig. 1). Positive prebiotic-mediated effects on gene expression have been 384 
evidenced in newborn animals because of the different regulation of circulating satiety 385 
hormones and genes involved in glucose transport and energy metabolism in offspring.
 
386 
30
 Findings supporting the influence of dietary prebiotics in modulation of gut 387 
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microbiota or their direct influence in PPAR-γ expression suggest a potential use for 388 
prebiotics in type-2 diabetes, hypertension in the absence of obesity and, a number of 389 
components of the metabolic syndrome.
 31
 Notably, the data presented in this study 390 
revealed significant differences of the prebiotic compounds assayed in PPAR expression 391 
evidencing the importance of the prebiotic structure on their potential physiological 392 
effects and utilization as adjuvants in therapeutic strategies. 393 
Fermentation of prebiotics with the subsequent production of SCFA plays a pivotal 394 
role in some beneficial activities in the gut.
 32
 Deficiencies in Fe absorption processes 395 
have been associated to acetic-induced inhibition of glucose metabolism in diabetic 396 
animal models.
 33
 In good accordance with these data, the decreased colon acetic acid 397 
concentration in the groups of animals fed with GOS-Lu and kojibiose likely associated 398 
inversely with MCH (Table 1), but not in animals fed with the 4’-galactosyl-kojibiose. 399 
Otherwise, the higher production of both propionic and butyric acid in the groups 400 
administered with the prebiotics GOS-Lu and kojibiose compounds could be 401 
hypothesized to favor low oxidative stress, due to Fe incorporation into cells, reflected 402 
in improved MCH values. This hypothesis is supported by the interaction of propionates 403 
with heme oxygenase leading to the production of precursors to the powerful 404 
antioxidant bilirubin.
 34
 Also, ketone body D-β-hydroxybutyrate (βOHB) has been also 405 
reported as an endogenous and specific inhibitor of class I histone deacetylases reducing 406 
oxidative stress.
 35
 It cannot be ruled out that butyrate and propionate constitute the main 407 
source of energy for host colonocytes and are also important for gastrointestinal health, 408 
immunity, and host metabolism contributing to maintain angiopoietin-like protein 4 409 
(ANGPTL4) levels stimulating additional routes to gut microbiota.
 36
 410 
Overall, the data presented indicate that administration of certain prebiotic structures 411 
could help preventing cellular alterations as consequence of the dietary micronutrient 412 
intake. 413 
 414 
5. CONCLUSIONS 415 
The data reported herein on the influence of different prebiotic compounds, reveal 416 
novel findings on how structural differences of prebiotics can affect Fe homeostasis in a 417 
Fe-deficient animal model. Physiological response(s) in Fe homeostasis can be 418 
modulated by the concurrent administration of supplements of Fe together with 419 
prebiotics. The data reported point to prebiotic-mediated beneficial effects to liver 420 
function that are reflected in higher Hb concentration (up to 17%) improving nutritional 421 
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status of the micronutrient. Accordingly, animals administered with GOS-Lu and 422 
kojibiose showed significantly higher MHC than those administered with the 423 
supplement of Fe alone. Moreover, feeding animals with potential prebiotic compounds 424 
decreased the Fe supplement-induced liver secretion of inflammatory bioactive hepcidin 425 
peptide, thus contributing to an improved intestinal absorption of the micronutrient. 426 
These effects were accompanied of different expression patterns of liver iron sensing 427 
biomarkers indicating their different influence in the cross-talk within the gut-liver axis. 428 
The fact that infants constitute a population at a high risk to suffer iron deficiency, 429 
points out the attractive potential use prebiotics in the formulation of infant foods for 430 
improving bowel function due to its prebiotic function and prevent the risk of nutritional 431 
deficiency in iron. However, further human trials are needed to support the clinical 432 
relevance of this potential nutritional intervention. 433 
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Figure 1. Hepatic expression of transferrin receptor (TfR2), interleukin (IL) -6, peroxisome 564 
activator receptor (PPAR)-γ and nuclear factor kappa (NFκ)-B in control and iron 565 
deficient (ID) animals and those administered with the supplement of Fe alone or together 566 
with the different potential prebiotic compounds (GOS-Lu, kojibiose or galactosyl-567 
kojibiose). Results are expressed as median (lower-upper limits) (n=7). Superscript symbols 568 
indicate statistically (P<0.05) significant differences. §, P=0.024; *,¢ P<0.05 relative to 569 
controls. 570 
 571 
 572 
  573 
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Figure 2. Plasma hepcidin peptide concentrations in control and iron deficient (ID) animals 574 
and those administered with the supplement of Fe alone or together with the different 575 
potential prebiotic compounds (GOS-Lu, kojibiose or galactosyl-kojibiose). Results are 576 
expressed as median (lower-upper limits) (n=7). Superscript letters indicate statistically 577 
(P<0.05) significant differences. 578 
 579 
  580 
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Table 1. Hematological parameters of control and iron deficient (ID) animals and those administered with the supplement of Fe alone or together with 581 
the different potential prebiotic compounds GOS-Lu, kojibiose, and galactosyl-kojibiose. Results are expressed as median (lower-upper limits) (n=7). a-582 
d Different superscript letters indicate significant (P<0.05) statistical differences. 583 
 
Control ID FeCl3 
Oligosaccharide + FeCl3 
 GOS-Lu Kojibiose Gal-kojibiose 
Hemoglobin, Hb (g/dL) 19.8 ± 0.7 
a
 11.1 ± 2.7 
d
 16.2 ± 0.2 
bc
 18.1 ± 1.3
 ab
 18.5 ± 0.9
 ab
 15.2 ± 1.0
 c
 
Hematocrit 55.3 ± 2.1 
a
 53.7 ± 1.4 
a
 56.0 ± 0.9 
ab
 54.0 ± 0.9 
a
 53.3 ± 1.3 
a
 58.4 ± 1.4 
b
 
Erythrocytes (x10
6
/mm
3
) 3.25 3.26 3.30 3.50 3.35 3.14 
MCV
1
 (x10
4
) 1.68 1.64 1.71 1.67 1.63 1.78 
MCH
2
 (pg) 35.7 ± 1.2 
a
 20.3 ± 5.5 
b
 28.9 ± 0.3 
cd
 33.0 ± 0.8 
cd
 34.6 ± 1.5 
a
 27.6 ± 2.4 
d
 
VSG
3
 (mm/h) 2.3 2.5 2.2 2.1 2.7 2.4 
1
 MCV, mean corpuscular volume – mean standard deviation (SD) = ±4.09 x10
-6
; 
2
 MCH, mean corpuscular hemoglobin concentration; 
3
VSG, 584 
corpuscular speed sedimentation 585 
  586 
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Table 2. Short chain fatty acids (SCFA) concentration in colon contents (µg/g feces) of control and iron deficient (ID) animals and those administered 587 
with the supplement of Fe alone or together with the different potential prebiotic compounds GOS-Lu, kojibiose, and galactosyl-kojibiose. Results are 588 
expressed as median (lower-upper limits) (n=7). a-d Different superscript letters indicate significant (P<0.05) statistical differences. 589 
SCFA Control ID FeCl3 
Oligosaccharide + FeCl3 
GOS-Lu Kojibiose Gal-kojibiose 
Formic 8.57 ± 1.06 
a
 14.49 ± 2.94 
b
 12.03 ± 2.32 
ab
 12.06 ± 0.26 
ab
 11.57 ± 2.54 
ab
 8.31 ± 2.50 
a
 
Acetic 1.41 ± 0.25 
a
 1.92 ± 1.07 
ab
 3.04 ± 1.24 
b
 2.24 ± 0.13 
ab
 1.81 ± 0.35 
a
 0.98 ± 0.10 
a
 
Propionic 0.54 ± 0.18 
ab
 0.50 ± 0.18 
ab
 0.96 ± 0.21 
c
 0.80 ± 0.07 
bc
 0.64 ± 0.20 
abc
 0.31 ± 0.02 
a
 
D/L-Lactic 0.21 ± 0.02 
ab
 0.18 ± 0.09 
a
 0.32 ± 0.07 
ab
 0.30 ± 0.07 
ab
 0.28 ± 0.09 
ab
 0.36 ± 0.03 
b
 
i-Butyric 0.24 ± 0.05 
a
 0.30 ± 0.11 
a
 0.62 ± 0.15 
b
 0.42 ± 0.13 
ab
 0.31 ± 0.09 
a
 0.21 ± 0.05 
a
 
i-Valeric 8.10 ± 1.17 
a
 15.20 ± 3.02 
c
 15.26 ± 2.83 
c
 12.71 ± 0.51 
b
 8.59 ± 0.60 
a
 5.71 ± 0.19 
a
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